# Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood

> **NCT02482051** · — · COMPLETED · sponsor: **Denver Health and Hospital Authority** · enrollment: 100 (actual)

## Conditions studied

- Bacteremia
- Enterobacteriaceae Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02482051
- **Lead sponsor:** Denver Health and Hospital Authority
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2022-01
- **Final completion:** 2022-01-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-03-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02482051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02482051, "Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02482051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*